Evidence map›Paper›PMID 12801736›Full record

Trial reportLancet (London, England)2003

Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial.

H A de Silva, M M D Fonseka, A Pathmeswaran, D G S Alahakone, G A Ratnatilake, S B Gunatilake, C D Ranasinha, D G Lalloo, J K Aronson, H J de Silva

Abstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Lancet (London, England), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. First aid interventions by laypeople for acute oral poisoning.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Antidotes for acute cardenolide (cardiac glycoside) poisoning.The Cochrane database of systematic reviews · 2006
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Indian Society of Critical Care Medicine Position Statement: Approach to a Patient with Poisoning in the Emergency Room and Intensive Care Unit.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Oleander and Datura Poisoning: An Update.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2019
    Article
  15. The Use of Activated Charcoal to Treat Intoxications.Deutsches Arzteblatt international · 2019
    Review
  16. Article
  17. Pharmacological treatment of cardiac glycoside poisoning.British journal of clinical pharmacology · 2016
    Review
  18. Article
  19. Review
  20. Cleistanthus collinus poisoning.Journal of emergencies, trauma, and shock · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

H A de SilvaFaculty of Medicine, Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka. asita@mfac.kln.ac.lk
M M D Fonseka
A Pathmeswaran
D G S Alahakone
G A Ratnatilake
S B Gunatilake
C D Ranasinha
D G Lalloo
J K Aronson
H J de Silva
University of Kelaniya · LKJaffna Teaching Hospital · LKLiverpool School of Tropical Medicine · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeliberate self-poisoning with yellow oleander seeds is common in Sri Lanka and is associated with severe cardiac toxicity and a mortality rate of about 10%. Specialised treatment with antidigoxin Fab fragments and temporary cardiac pacing is expensive and not widely available. Multiple-dose activated charcoal binds cardiac glycosides in the gut lumen and promotes their elimination. We aimed to assess the efficacy of multiple-dose activated charcoal in the treatment of patients with yellow-oleander poisoning.

methodsOn admission, participants received one dose of activated charcoal and were then randomly assigned either 50 g of activated charcoal every 6 h for 3 days or sterile water as placebo. A standard treatment protocol was used in all patients. We monitored cardiac rhythm and did 12-lead electocardiographs as needed. Death was the primary endpoint, and secondary endpoints were life-threatening cardiac arrhythmias, dose of atropine used, need for cardiac pacing, admission to intensive care, and number of days in hospital. Analysis was by intention to treat.

findings201 patients received multiple-dose activated charcoal and 200 placebo. There were fewer deaths in the treatment group (five [2.5%] vs 16 [8%]; percentage difference 5.5%; 95% CI 0.6-10.3; p=0.025), and we noted difference in favour of the treatment group for all secondary endpoints, apart from number of days in hospital. The drug was safe and well tolerated.

interpretationMultiple-dose activated charcoal is effective in reducing deaths and life-threatening cardiac arrhythmias after yellow oleander poisoning and should be considered in all patients. Use of activated charcoal could reduce the cost of treatment.

Indexed as

AdolescentAdultAgedCharcoalChildHumansMiddle AgedPoisoningSingle-Blind MethodSri LankaThevetiaCharcoal

Identifiers

PMID12801736
OpenAlexW2140759277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.